Silence Therapeutics financials at a glance

Year Year 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Rev. Revenue
$0.16M $0.51M $1.95M $4.05M $2.21M $1.72M $2.37M $0.69M $0.16M $0.12M $0.02M $0.00M $0.77M $0.02M $0.00M $0.24M $5.48M $12.42M $17.50M $25.38M $0.00M
GM % Gross Margin %
0.00% -226.21% -63.61% -19.66% -203.89% -194.40% -146.05% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 31.34% 39.94% 37.83% 59.34% 0.00%
OM Operating Margin
0.00% 0.00% -219.19% -143.01% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -277.66% -195.48% 0.00%
EPS Earnings Per Share
$-1.64 $-1.74 $-1.53 $-1.49 $0.00
Div. Dividends
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
PR % Payout Ratio %
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Sha. Shares
0.48m 0.48m 1.81m 2.4m 2.4m 2.7m 5.6m 11.54m 37.43m 47.06m 52.1m 69.8m 69.8m 69.99m 71.07m 78.37m 83.31m 29.93m 35.89m 0m 46.62m
OCF Operating Cash Flow
$-2.48M $-2.78M $-4.03M $-3.83M $-6.98M $-4.65M $-10.55M $-5.11M $-4.88M $-6.76M $-9.46M $-8.26M $-10.07M $-9.60M $-16.76M $1.73M $-10.78M $6.81M $-45.46M $-39.35M $0.00M
FCF Free Cash Flow
$-2.50M $-2.83M $-4.08M $-4.14M $-7.12M $-4.69M $-10.58M $-5.12M $0.00M $-6.88M $-9.80M $-9.10M $-10.56M $-9.77M $-16.89M $1.72M $-11.29M $1.08M $-45.60M $-36.50M $0.00M
FCFS Free Cash Flow Per Share
$-5.24 $-2.35 $-2.19 $-1.88 $-3.03 $-1.81 $-1.95 $-0.58 $-0.26 $-0.16 $-0.19 $-0.14 $-0.15 $-0.14 $-0.24 $0.02 $-0.14 $0.06 $-1.43 $-1.06 $0.00